Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
Miriam T Y LeungJustin P TurnerClara MarquinaJenni IlomakiTim TranJ Simon BellPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
Two-thirds of patients demonstrated good adherence to oral bisphosphonates over 12 months following hip fracture. Efforts to further increase post-discharge antiresorptive use should be sex-specific and address possible persistent uncertainty around delaying treatment initiation.